Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer

Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer

EVIDENS was a prospective, non-interventional, longitudinal study conducted in non-small cell lung cancer (NSCLC) patients receiving nivolumab in France. It recruited adults with pathologically confirmed NSCLC who initiated nivolumab between October 2016 and November 2017; the final results are repo...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac, Nicolas Benoit, Pierre Bombaron, Denis Moro-Sibilot, Bernard Asselain, Clarisse Audigier-Valette, Florence Brellier, François-Emery Cotté, Yaacoub Khalife, Maurice Pérol
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:OncoImmunology
Subjects:
EVIDENS
France
nivolumab
non-small cell lung cancer
observational study
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2025.2492932
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2025.2492932

Similar Items